New MMR Vaccine: FDA Approves Priorix®

New MMR Vaccine: FDA Approves Priorix®

July 25, 2022 — The FDA has approved Priorix, the first new MMR vaccine approved in the U.S. in 50 years.

On June 6, GlaxoSmithKline announced U.S. approval of Priorix for the prevention of measles, mumps and rubella.

The vaccine is delivered in a 2-dose series, with the first dose at 12 to 15 months of age, and the second dose at 4 to 6 years of age.

Priorix may also be administered as a 2nd dose to people who have previously received the first dose of another MMR-containing vaccine.

The most commonly reported adverse reactions were pain, redness, swelling, loss of appetite, irritability, drowsiness and fever.

Measles has been making a comeback in recent years, partly due to the coronavirus disruption to routine childhood immunizations.

“Outbreaks of measles in recent years demonstrate how quickly diseases can return without widespread immunization. Missed vaccinations during the pandemic makes children even more vulnerable to vaccine-preventable diseases like measles,” said Temi Folaranmi at GlaxoSmithKline.

Priorix has been sold internationally for 25 years, first in Germany and now in more than 100 countries. It is the first new MMR vaccine in the U.S. in 50 years, where it will compete with Merck’s M-M-R II vaccine.

New MMR Vaccine: FDA Approves Priorix®

Source: GSK announces US FDA approval of Priorix for the prevention of measles, mumps and rubella in individuals 12 months of age and older. News release. GSK; June 6, 2022.

Vaccine Side Effects & Injury Lawyers

Verified 100% Secure Site

If you or a loved one has been the victim of a vaccine side effect, you should contact a vaccine lawyer with experience in this type of complex litigation.

We have recently partnered with Schmidt & Clark, LLP; a Nationally recognized law firm who handles vaccine lawsuits in all 50 states.

The lawyers at the firm offer a Free Confidential Case Evaluation and may be able to obtain financial compensation for you or a loved one by filing a vaccine lawsuit or claim with The National Vaccine Injury Compensation Program. Contact Schmidt & Clark today by using the form below or by calling them directly at (866) 223-3784.

Previous Article

Leave a Reply

Your email address will not be published.